Patience is key
Furthermore, the preclinical works which unravel the effects of GLP-1 in ocular dynamics and the preclinical literature regarding GLP-1RA use in the management of several neuro-ophthalmic conditions, including diabetic retinopathy (DR), glaucoma, and idiopathic intracranial hypertension (IIH) are discussed
Drug manufacturers named in GLP-1 lawsuits include: GLP-1 receptor agonists are a class of medications that mimic glucagon-like peptide-1, a naturally occurring hormone involved in blood sugar regulation, digestion, and appetite control
Pro-inflammatory cytokines from activation of microglia can lead to the formation of A1 astrocytes, which are implicated in the pathogenesis of glaucoma and have diminished ability to phagocytose and poorer synapse support [96, 97]
These changes help to improve glucose levels and can reduce how many calories youre eating, which is why GLP-1 receptor agonists are used for both diabetes and obesity